High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases
Journal of Neuro-Oncology Aug 09, 2017
Ge M, et al. – The association of epidermal growth factor receptor (EGFR) mutations and brain metastasis (BMs) was examined in non–small cell lung cancer (NSCLC). A higher incidence of EGFR mutations was unveiled in NSCLC patients with BMs. In those with mutant EGFR, results highlighted a higher frequency of BMs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries